[TREATMENT OF PERIPHERAL VERTIGO SYNDROMES WITH A SOLUBLE DERIVATIVE OF PYRIMIDO-PYRIMIDINE. PATHOGENIC CONSIDERATIONS].
D002560:Cerebrovascular Circulation; D002574:Cervical Vertebrae; D004176:Dipyridamole; D004487:Edema; D006311:Hearing Disorders; D006801:Humans; D007022:Hypotension; D007759:Labyrinth Diseases; D007761:Labyrinthine Fluids; D008575:Meniere Disease; D010040:Otosclerosis; D010523:Peripheral Nervous System Diseases; D013122:Spinal Diseases; D013564:Sympathetic Nervous System; D013577:Syndrome; D014116:Toxicology; D014717:Vertigo
D004176:Dipyridamole
CEREBROVASCULAR CIRCULATION; CERVICAL VERTEBRAE; DIPYRIDAMOLE; EDEMA; HEARING DISORDERS; HYPOTENSION; LABYRINTH DISEASES; LABYRINTHINE FLUIDS; MENIERE'S DISEASE; OTOSCLEROSIS; PERIPHERAL NERVE DISEASES; SPINAL DISEASES; SYMPATHETIC NERVOUS SYSTEM; TOXICOLOGIC REPORT; VERTIGO
TRATAMIENTO DE LOS S'INDROMES VERTIGINOSOS PERIF'ERICOS CON UN DERIVADO SOLUBLE DE LA PIRIMIDO-PIRIMIDINA. CONSIDERCIONES PATOG'ENICAS.